These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29209099)

  • 21. Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals.
    Desgranges C; Carvajal P; Afani A; Guzman MA; Sasco A; Sepulveda C
    Immunol Lett; 2001 Mar; 76(2):115-7. PubMed ID: 11274729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Association between the CCR5Δ32 Polymorphism and Sporadic Esophageal Cancer in Punjab, North-West India.
    Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR; Singh H; Guleria K
    Asian Pac J Cancer Prev; 2015; 16(10):4291-5. PubMed ID: 26028088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic.
    Sácká L; Hodek J; Machala L; Malý M; Weber J
    Epidemiol Mikrobiol Imunol; 2019; 68(3):138-143. PubMed ID: 31914779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
    Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
    Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].
    Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response.
    Brumme ZL; Chan KJ; Dong W; Hogg R; O'Shaughnessy MV; Montaner JS; Harrigan PR
    AIDS; 2001 Nov; 15(17):2259-66. PubMed ID: 11698699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
    Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic distribution of CCR5 and CCR2 genes in an Italian population sample.
    Romano-Spica V; Ianni A; Arzani D; Cattarini L; Majore S; Dean M
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):99-101. PubMed ID: 10659048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR5Δ32 in HCV infection, HCV/HIV co-infection, and HCV-related diseases.
    Ellwanger JH; Leal BK; Valverde-Villegas JM; Simon D; Marangon CG; Mattevi VS; Lazzaretti RK; Sprinz E; Kuhmmer R; Chies JAB
    Infect Genet Evol; 2018 Apr; 59():163-166. PubMed ID: 29408489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection.
    Yu AQ; Ding Y; Lu ZY; Hao YZ; Teng ZP; Yan SR; Li DS; Zeng Y
    Mol Med Rep; 2018 Jan; 17(1):243-249. PubMed ID: 29115572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.